Trading Ideas Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.75 USD | -0.56% |
|
-7.94% | -18.35% |
| 02-23 | Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion | RE |
| 02-12 | Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade | MT |
Trading Ideas
Search
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition